Faculty of Clinical Engineering, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.
Faculty of Medical Technology, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.
J Med Virol. 2017 Oct;89(10):1830-1836. doi: 10.1002/jmv.24862. Epub 2017 Jun 15.
Human herpesvirus 6 (HHV-6), a member of the betaherpesvirus family, has two distinct species: HHV-6A and HHV-6B. HHV-6B real-time reverse transcription polymerase chain reaction (RT-PCR) has been used to distinguish between active and latent viral infection. In this study, we developed a real-time RT-PCR assay to detect HHV-6A-specific transcripts and evaluated its reliability for analysis of clinical samples. To develop HHV-6A-specific real-time RT-PCR assays, three different classes of gene transcripts (immediate early: U90; early: U12; and late: U100) were selected as targets. Serial d ilutions of plasmid DNAs containing target sequences and RNAs extracted from HHV-6A-infected cells were used to determine assay specificity and sensitivity. Peripheral blood mononuclear cells (PBMCs) collected from patients with either primary or reactivated HHV-6B infection, and one patient with X-linked severe combined immunodeficiency (X-SCID) with HHV-6A reactivation, were used to evaluate assay reliability. The HHV-6A-specific real-time RT-PCR assays amplified plasmids containing the target sequences at concentrations between 10 and 1 × 10 copies per reaction. The intra-assay coefficients of variation were less than 5%. The three classes of HHV-6A gene transcripts were not detected in any HHV-6B sample isolated from the patients. In the X-SCID patient, high copy numbers of HHV-6A U12 and U100 transcripts were detected in PBMC samples during viremia. Thus, we successfully established highly sensitive and reproducible real-time RT-PCR methods targeting three classes of HHV-6A gene transcripts. This method should be useful for discriminating active HHV-6A infection from either latent infection or chromosomally integrated HHV-6A (ciHHV-6A).
人类疱疹病毒 6 型(HHV-6)是β疱疹病毒家族的一员,有两个不同的种:HHV-6A 和 HHV-6B。HHV-6B 实时逆转录聚合酶链反应(RT-PCR)已被用于区分活跃和潜伏的病毒感染。在这项研究中,我们开发了一种实时 RT-PCR 检测方法来检测 HHV-6A 特异性转录本,并评估其分析临床样本的可靠性。为了开发 HHV-6A 特异性实时 RT-PCR 检测方法,选择了三个不同类别的基因转录本(即刻早期:U90;早期:U12;晚期:U100)作为靶标。使用包含靶序列的质粒 DNA 和从 HHV-6A 感染细胞中提取的 RNA 的连续稀释液来确定检测方法的特异性和灵敏度。从原发性或再激活 HHV-6B 感染的患者以及一名 X 连锁严重联合免疫缺陷(X-SCID)合并 HHV-6A 再激活的患者中收集外周血单核细胞(PBMC),用于评估检测方法的可靠性。HHV-6A 特异性实时 RT-PCR 检测方法可扩增浓度在 10 至 1×10 拷贝/反应之间的包含靶序列的质粒。内实验变异系数小于 5%。从患者中分离的任何 HHV-6B 样本中均未检测到这三种 HHV-6A 基因转录本。在 X-SCID 患者中,在病毒血症期间,PBMC 样本中检测到高拷贝数的 HHV-6A U12 和 U100 转录本。因此,我们成功建立了针对三种 HHV-6A 基因转录本的高度敏感和可重复的实时 RT-PCR 方法。该方法对于区分活跃的 HHV-6A 感染与潜伏感染或染色体整合的 HHV-6A(ciHHV-6A)应该是有用的。